Search

Dale R. Miller

Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1673, 1693
Total Applications
838
Issued Applications
502
Pending Applications
84
Abandoned Applications
276

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16428259 [patent_doc_number] => 10828320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Ophthalmic compositions with improved dessication protection and retention [patent_app_type] => utility [patent_app_number] => 16/721443 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3535 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721443 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/721443
Ophthalmic compositions with improved dessication protection and retention Dec 18, 2019 Issued
Array ( [id] => 20621612 [patent_doc_number] => 12589106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => Nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier [patent_app_type] => utility [patent_app_number] => 17/416573 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7364 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/416573
Nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier Dec 10, 2019 Issued
Array ( [id] => 19440021 [patent_doc_number] => 12090248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-17 [patent_title] => Crosslinked hyaluronic acid, hyaluronic acid hydrogel, and method for producing crosslinked hyaluronic acid and hyaluronic acid hydrogel [patent_app_type] => utility [patent_app_number] => 17/311070 [patent_app_country] => US [patent_app_date] => 2019-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14362 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311070 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/311070
Crosslinked hyaluronic acid, hyaluronic acid hydrogel, and method for producing crosslinked hyaluronic acid and hyaluronic acid hydrogel Dec 5, 2019 Issued
Array ( [id] => 18724269 [patent_doc_number] => 20230338403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR REDUCING PAIN [patent_app_type] => utility [patent_app_number] => 17/798270 [patent_app_country] => US [patent_app_date] => 2019-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9278 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798270 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/798270
COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR REDUCING PAIN Dec 5, 2019 Pending
Array ( [id] => 17533705 [patent_doc_number] => 20220112314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => ULTRASOUND AND PRESSURE ASSISTED METHOD FOR EXTRACTING PECTIN RICH IN RG-I [patent_app_type] => utility [patent_app_number] => 17/267487 [patent_app_country] => US [patent_app_date] => 2019-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267487 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/267487
Ultrasound and pressure assisted method for extracting pectin rich in RG-I Dec 2, 2019 Issued
Array ( [id] => 15765917 [patent_doc_number] => 20200113976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => RAPID-ACTING INSULIN FORMULATION COMPRISING A SUBSTITUTED ANIONIC COMPOUND [patent_app_type] => utility [patent_app_number] => 16/687339 [patent_app_country] => US [patent_app_date] => 2019-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16687339 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/687339
Rapid-acting insulin formulation comprising a substituted anionic compound Nov 17, 2019 Issued
Array ( [id] => 17356677 [patent_doc_number] => 20220017473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => INDAZOLYLCYANOETHYLAMINO COMPOUND, COMPOSITIONS OF SAME, METHOD OF MAKING, AND METHODS OF USING THEREOF [patent_app_type] => utility [patent_app_number] => 17/294761 [patent_app_country] => US [patent_app_date] => 2019-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12977 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294761 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/294761
Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof Nov 13, 2019 Issued
Array ( [id] => 19969673 [patent_doc_number] => 12338265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-24 [patent_title] => Crosslinked artificial nucleic acid ALNA [patent_app_type] => utility [patent_app_number] => 17/292963 [patent_app_country] => US [patent_app_date] => 2019-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36537 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292963 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292963
Crosslinked artificial nucleic acid ALNA Nov 10, 2019 Issued
Array ( [id] => 17065796 [patent_doc_number] => 20210268011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => AMPK ACTIVATING AGENT [patent_app_type] => utility [patent_app_number] => 16/759818 [patent_app_country] => US [patent_app_date] => 2019-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7056 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759818 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/759818
AMPK activating agent Nov 9, 2019 Issued
Array ( [id] => 17334560 [patent_doc_number] => 20220000891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => METHODS OF SUPPORTING GASTROINTESTINAL HOMEOSTASIS [patent_app_type] => utility [patent_app_number] => 17/291481 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81606 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291481 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/291481
Methods of supporting gastrointestinal homeostasis Nov 7, 2019 Issued
Array ( [id] => 18994588 [patent_doc_number] => 11911405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Methods of selectively modulating gastrointestinal microbial growth [patent_app_type] => utility [patent_app_number] => 17/292132 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 50 [patent_no_of_words] => 98863 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292132 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292132
Methods of selectively modulating gastrointestinal microbial growth Nov 7, 2019 Issued
Array ( [id] => 19256310 [patent_doc_number] => 12016334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Composition comprising sulphated galactose, and implementations thereof [patent_app_type] => utility [patent_app_number] => 16/955326 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 17438 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955326 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955326
Composition comprising sulphated galactose, and implementations thereof Nov 7, 2019 Issued
Array ( [id] => 16492361 [patent_doc_number] => 10858386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Drug compound and purification methods thereof [patent_app_type] => utility [patent_app_number] => 16/674786 [patent_app_country] => US [patent_app_date] => 2019-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 37769 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16674786 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/674786
Drug compound and purification methods thereof Nov 4, 2019 Issued
Array ( [id] => 15831881 [patent_doc_number] => 20200131222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => COMPOSITION FOR ENHANCING EXERCISE ABILITY OR ANTI-FATIGUE COMPRISING NOVEL GINSENOSIDE [patent_app_type] => utility [patent_app_number] => 16/666586 [patent_app_country] => US [patent_app_date] => 2019-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9621 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666586 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/666586
Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside Oct 28, 2019 Issued
Array ( [id] => 17073730 [patent_doc_number] => 11110109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-07 [patent_title] => Water soluble O-glycosyl flavonoid compositions and methods for preparing same [patent_app_type] => utility [patent_app_number] => 16/660111 [patent_app_country] => US [patent_app_date] => 2019-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3367 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660111 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/660111
Water soluble O-glycosyl flavonoid compositions and methods for preparing same Oct 21, 2019 Issued
Array ( [id] => 17297823 [patent_doc_number] => 20210393662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => USE OF SGLT2 INHIBITORS TO TREAT PRIMARY SCLEROSING CHOLANGITIS [patent_app_type] => utility [patent_app_number] => 17/285675 [patent_app_country] => US [patent_app_date] => 2019-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/285675
USE OF SGLT2 INHIBITORS TO TREAT PRIMARY SCLEROSING CHOLANGITIS Oct 16, 2019 Abandoned
Array ( [id] => 15800103 [patent_doc_number] => 20200123194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => COMPOSITION COMPRISING NOVEL GINSENOSIDE [patent_app_type] => utility [patent_app_number] => 16/656029 [patent_app_country] => US [patent_app_date] => 2019-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16656029 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/656029
Composition comprising novel ginsenoside Oct 16, 2019 Issued
Array ( [id] => 19808290 [patent_doc_number] => 12239649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia [patent_app_type] => utility [patent_app_number] => 17/281598 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9536 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281598 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/281598
Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia Sep 30, 2019 Issued
Array ( [id] => 17334564 [patent_doc_number] => 20220000895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => NEW AGENTS FOR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIA [patent_app_type] => utility [patent_app_number] => 17/281276 [patent_app_country] => US [patent_app_date] => 2019-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4375 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281276 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/281276
Agents for use in the treatment of cardiac arrhythmia Sep 29, 2019 Issued
Array ( [id] => 17383753 [patent_doc_number] => 20220031605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => TARGETED DRUG DELIVERY SYSTEM TO BE USED IN TREATING OSTEOMYELITIS [patent_app_type] => utility [patent_app_number] => 17/278467 [patent_app_country] => US [patent_app_date] => 2019-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1491 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278467 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/278467
TARGETED DRUG DELIVERY SYSTEM TO BE USED IN TREATING OSTEOMYELITIS Sep 22, 2019 Abandoned
Menu